Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review

Elizabeth M. Williamson, Thomas Brendler

Open source

DOI
10.1002/ptr.70090
Published
2025-09-18
Container
Phytotherapy Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ptr.70090,
  title = {Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review},
  author = {Elizabeth M. Williamson and Thomas Brendler},
  year = {2025},
  journal = {Phytotherapy Research},
  doi = {10.1002/ptr.70090},
  url = {https://doi.org/10.1002/ptr.70090}
}

RIS

TY  - JOUR
TI  - Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
AU  - Elizabeth M. Williamson
AU  - Thomas Brendler
PY  - 2025
JO  - Phytotherapy Research
DO  - 10.1002/ptr.70090
UR  - https://doi.org/10.1002/ptr.70090
ER  - 

APA

Williamson, E. M., & Brendler, T. (2025). Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review. Phytotherapy Research. https://doi.org/10.1002/ptr.70090

Source records